Status of Regulatory Approvals

On November 26, 2012, WellPoint, Inc. ("WellPoint") submitted certain information to the Washington State Office of the Insurance Commissioner (the "Washington OIC"), including a chart detailing the status of state regulatory approvals with respect to WellPoint's pending acquisition of AMERIGROUP Corporation ("Amerigroup"), which was previously announced on July 9, 2012. The chart, which is attached to this Current Report on Form 8-K as Exhibit 99.1 and incorporated herein by reference, indicates that all states except Washington have approved WellPoint's proposed acquisition of Amerigroup, in certain cases with limited conditions, including the states of Florida, Georgia, Kansas, Louisiana, Maryland, Nevada, New Jersey, New Mexico, New York, Ohio, Tennessee and Texas. In connection with the submission of information to the Washington OIC, WellPoint also provided the Washington OIC with an update on the status of the United States Department of Justice (the "DOJ") antitrust review of the proposed acquisition. WellPoint and Amerigroup expect the DOJ to complete its antitrust review by the first week of December 2012. The closing of WellPoint's acquisition of Amerigroup is expected to occur as soon as practicable after the Washington OIC's hearing to consider, and approval of, the proposed acquisition. The Washington OIC has not yet scheduled a date for the hearing.

Sale of Virginia Health Plan

As previously announced on September 28, 2012, Amerigroup entered into a definitive agreement to sell its Virginia health plan to Inova Health System. Amerigroup expects to close the sale of its Virginia health plan on November 30, 2012, subject to the receipt of customary regulatory approvals and standard closing conditions.

Forward-Looking Statements

This Current Report on Form 8-K contains certain "forward-looking" statements as that term is defined by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements that are predictive in nature, that depend on or relate to future events or conditions, or that include words such as "believes", "anticipates", "expects", "may", "will", "should", "estimates", "intends", "plans" and other similar expressions are forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements as a result of, but not limited to, the following factors: the failure to obtain regulatory approval or consummate the sale of Amerigroup Virginia, Inc., the failure to receive, on a timely basis or otherwise, the required approvals by government or regulatory agencies related to the WellPoint transaction; the risk that a condition to closing of the proposed WellPoint transaction may not be satisfied; Amerigroup's and WellPoint's ability to consummate the merger; the ability of Amerigroup to retain and hire key personnel and maintain relationships with providers or other business partners pending the consummation of the WellPoint transaction; and the impact of legislative, regulatory and competitive changes and other risk factors relating to the industries in which Amerigroup and WellPoint operate, as detailed from time to time in each of Amerigroup's and WellPoint's reports filed with the Securities and Exchange Commission. There can be no assurance that the proposed transaction will in fact be consummated.

(d) Exhibits.

   Exhibit
   Number    Description

   99.1      Form A Approvals from Insurance Regulators as of November 26, 2012